[
  {
    "qas": [
      {
        "answers": [
          {
            "text": "JOINT VENTURE AGREEMEN",
            "answer_start": 43
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Document Name",
        "question": "Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract",
        "is_impossible": false
      },
      {
        "answers": [
          {
            "text": "SIMPLY HERBAL",
            "answer_start": 264
          },
          {
            "text": "MJ Syndicated, Inc.",
            "answer_start": 172
          },
          {
            "text": "individually and collectively the Joint Venture Participants \"JVP\"",
            "answer_start": 358
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Parties",
        "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
        "is_impossible": false
      },
      {
        "answers": [
          {
            "text": "27th day of November 2018",
            "answer_start": 112
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Agreement Date",
        "question": "Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract",
        "is_impossible": false
      },
      {
        "answers": [
          {
            "text": "The Joint Venture is a fixed term Joint Venture beginning November 27, 2018 and ending November 30th, 2019 or as otherwise provided in this Agreement.",
            "answer_start": 1341
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Effective Date",
        "question": "Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\u00a0",
        "is_impossible": false
      },
      {
        "answers": [
          {
            "text": "The Joint Venture is a fixed term Joint Venture beginning November 27, 2018 and ending November 30th, 2019 or as otherwise provided in this Agreement.",
            "answer_start": 1341
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Expiration Date",
        "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Renewal Term",
        "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Notice Period To Terminate Renewal",
        "question": "Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "By this Agreement the Participants enter into a general Joint Venture (the \"Joint Venture\") in accordance with the laws of The State of Florida.",
            "answer_start": 863
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Governing Law",
        "question": "Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country's law governs the interpretation of the contract?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Most Favored Nation",
        "question": "Highlight the parts (if any) of this contract related to \"Most Favored Nation\" that should be reviewed by a lawyer. Details: Is there a clause that if a third party gets better terms on the licensing or sale of technology/goods/services described in the contract, the buyer of such technology/goods/services under the contract shall be entitled to those better terms?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "No Participant will engage in any business, venture or transaction, whether directly or indirectly, that might be competitive with the business of the Joint Venture or that would be in direct conflict of",
            "answer_start": 15466
          },
          {
            "text": "interest to the Joint Venture without the unanimous written consent of the remaining Participants.",
            "answer_start": 15705
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Non-Compete",
        "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector?\u00a0",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Exclusivity",
        "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\u00a0 commitment with the counterparty? This includes a commitment to procure all \u201crequirements\u201d from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\u00a0 collaborating or working with other parties), whether during the contract or\u00a0 after the contract ends (or both).",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__No-Solicit Of Customers",
        "question": "Highlight the parts (if any) of this contract related to \"No-Solicit Of Customers\" that should be reviewed by a lawyer. Details: Is a party restricted from contracting or soliciting customers or partners of the counterparty, whether during the contract or after the contract ends (or both)?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Competitive Restriction Exception",
        "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__No-Solicit Of Employees",
        "question": "Highlight the parts (if any) of this contract related to \"No-Solicit Of Employees\" that should be reviewed by a lawyer. Details: Is there a restriction on a party\u2019s soliciting or hiring employees and/or contractors from the\u00a0 counterparty, whether during the contract or after the contract ends (or both)?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Non-Disparagement",
        "question": "Highlight the parts (if any) of this contract related to \"Non-Disparagement\" that should be reviewed by a lawyer. Details: Is there a requirement on a party not to disparage the counterparty?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "Written notice of intention to withdraw must be served in writing upon the remaining Participants at least Thirty (30) business days prior to the withdrawal date.",
            "answer_start": 9408
          },
          {
            "text": "Any Participant will have the right to voluntarily withdraw from the Joint Venture at any time",
            "answer_start": 9312
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Termination For Convenience",
        "question": "Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\u00a0 contract without cause (solely by giving a notice and allowing a waiting\u00a0 period to expire)?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Rofr/Rofo/Rofn",
        "question": "Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Change Of Control",
        "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "Title to all Joint Venture Property will remain in the name of the Joint Venture.",
            "answer_start": 14636
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Anti-Assignment",
        "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Revenue/Profit Sharing",
        "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or\u00a0services?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Price Restrictions",
        "question": "Highlight the parts (if any) of this contract related to \"Price Restrictions\" that should be reviewed by a lawyer. Details: Is there a restriction on the\u00a0 ability of a party to raise or reduce prices of technology, goods, or\u00a0 services provided?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Minimum Commitment",
        "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Volume Restriction",
        "question": "Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one party\u2019s use of the product/services exceeds certain threshold?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Ip Ownership Assignment",
        "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created\u00a0 by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Joint Ip Ownership",
        "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__License Grant",
        "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Non-Transferable License",
        "question": "Highlight the parts (if any) of this contract related to \"Non-Transferable License\" that should be reviewed by a lawyer. Details: Does the contract limit the ability of a party to transfer the license being granted to a third party?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Affiliate License-Licensor",
        "question": "Highlight the parts (if any) of this contract related to \"Affiliate License-Licensor\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant by affiliates of the licensor or that includes intellectual property of affiliates of the licensor?\u00a0",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Affiliate License-Licensee",
        "question": "Highlight the parts (if any) of this contract related to \"Affiliate License-Licensee\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant to a licensee (incl. sublicensor) and the affiliates of such licensee/sublicensor?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Unlimited/All-You-Can-Eat-License",
        "question": "Highlight the parts (if any) of this contract related to \"Unlimited/All-You-Can-Eat-License\" that should be reviewed by a lawyer. Details: Is there a clause granting one party an \u201centerprise,\u201d \u201call you can eat\u201d or unlimited usage license?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Irrevocable Or Perpetual License",
        "question": "Highlight the parts (if any) of this contract related to \"Irrevocable Or Perpetual License\" that should be reviewed by a lawyer. Details: Does the contract contain a\u00a0 license grant that is irrevocable or perpetual?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Source Code Escrow",
        "question": "Highlight the parts (if any) of this contract related to \"Source Code Escrow\" that should be reviewed by a lawyer. Details: Is one party required to deposit its source code into escrow with a third party, which can be released to the counterparty upon the occurrence of certain events (bankruptcy,\u00a0 insolvency, etc.)?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "This duty continues to apply to any transactions undertaken after the Joint Venture has been dissolved but before the affairs of the Joint Venture have been completely wound up by the surviving Participant or Participants or their agent or agents.",
            "answer_start": 16463
          },
          {
            "text": "Each Participant must account to the Joint Venture for any benefit derived by that Participant without the consent of the other Participants from any transaction concerning the Joint Venture or any use by that Participant of the Joint Venture property, name or business connection.",
            "answer_start": 16180
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Post-Termination Services",
        "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
        "is_impossible": false
      },
      {
        "answers": [
          {
            "text": "Not more than one (1) audit will be required by any or all of the Participants for any fiscal year.",
            "answer_start": 6982
          },
          {
            "text": "The audit will be performed by an accounting firm acceptable to all the Participants.",
            "answer_start": 6896
          },
          {
            "text": "The cost of the audit will be borne by the Joint Venture.",
            "answer_start": 6838
          },
          {
            "text": "Any of the Participants will have the right to request an audit of the Joint Venture books.",
            "answer_start": 6746
          },
          {
            "text": "Accurate and complete books of account of the transactions of the Joint Venture will be kept in accordance with generally accepted accounting principles (GAAP) and at all reasonable times will be available and open to inspection and examination by any Participant.",
            "answer_start": 5188
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Audit Rights",
        "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\u00a0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Uncapped Liability",
        "question": "Highlight the parts (if any) of this contract related to \"Uncapped Liability\" that should be reviewed by a lawyer. Details: Is a party\u2019s liability uncapped upon the breach of its obligation in the contract? This also includes uncap liability for a particular type of breach such as IP infringement or breach of confidentiality obligation.",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "A Participant will not be liable to the Joint Venture, or to any other Participant, for any mistake or error in judgment or for any act or omission done in good faith and believed to be within the scope of authority conferred or implied by this Agreement or the Joint Venture.",
            "answer_start": 18787
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Cap On Liability",
        "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party\u2019s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Liquidated Damages",
        "question": "Highlight the parts (if any) of this contract related to \"Liquidated Damages\" that should be reviewed by a lawyer. Details: Does the contract contain a clause that would award either party liquidated damages for breach or a fee upon the termination of a contract (termination fee)?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Warranty Duration",
        "question": "Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\u00a0 warranty against defects or errors in technology, products, or services\u00a0 provided under the contract?",
        "is_impossible": true
      },
      {
        "answers": [
          {
            "text": "The Joint Venture may acquire insurance on behalf of any Participant, employee, agent or other person engaged in the business interest of the Joint Venture against any liability asserted against them or incurred by them while acting in good faith on behalf of the Joint Venture.",
            "answer_start": 19086
          }
        ],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Insurance",
        "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
        "is_impossible": false
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Covenant Not To Sue",
        "question": "Highlight the parts (if any) of this contract related to \"Covenant Not To Sue\" that should be reviewed by a lawyer. Details: Is a party restricted from contesting the validity of the counterparty\u2019s ownership of intellectual property or otherwise bringing a claim against the counterparty for matters unrelated to the contract?",
        "is_impossible": true
      },
      {
        "answers": [],
        "id": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT__Third Party Beneficiary",
        "question": "Highlight the parts (if any) of this contract related to \"Third Party Beneficiary\" that should be reviewed by a lawyer. Details: Is there a non-contracting party who is a beneficiary to some or all of the clauses in the contract and therefore can enforce its rights against a contracting party?",
        "is_impossible": true
      }
    ],
    "context": "Exhibit 99.01 JOINT VENTURE AGREEMENT THIS JOINT VENTURE AGREEMENT (the \"Agreement\") made and entered into this 27th day of November 2018 (the \"Execution Date\"),\n\nBETWEEN: MJ Syndicated, Inc. a Florida Corporation of _______________________________, FL 33436 And\n\nSIMPLY HERBALS, Nervanah Herbal Medicine Company of _______________________________TN 37660\n\n(individually and collectively the Joint Venture Participants \"JVP\").\n\nBACKGROUND:\n\nThe JVP wish to associate themselves in business of Selling a variety of Health- related products.\n\nThis Agreement sets out the terms and conditions that govern the Joint Venture.\n\nIN CONSIDERATION OF and as a condition of the JVP entering into this Agreement and other valuable consideration, the receipt and sufficiency of which consideration is acknowledged, the parties to this Agreement agree as follows:\n\nFormation\n\nBy this Agreement the Participants enter into a general Joint Venture (the \"Joint Venture\") in accordance with the laws of The State of Florida. The rights and obligations of the JVP will be as stated in the applicable legislation of The State of Florida except as otherwise provided in this Agreement.\n\nName\n\nA.\n\nB.\n\n1.\n\n\n\n\n\nThe firm name of the Joint Venture will be: TBD\n\nPurpose\n\nThe purpose of the Joint Venture will be: Manufacturing and Selling Health Related products.\n\nThe Joint Venture is a fixed term Joint Venture beginning November 27, 2018 and ending November 30th, 2019 or as otherwise provided in this Agreement. Where the Joint Venture is entered for a fixed term and the Joint Venture continues after the expiration of that term then in the absence of an express new agreement, the rights and duties of the Participants remain the same as they were at the expiration of that term so far as those terms are consistent with a Joint Venture at will.\n\nPlace of Business\n\nThe principal office of the business of the Joint Venture will be located at__________________________, FL 33434 or such other place as the Participants may from time to time designate.\n\nCapital Contributions\n\nEach of the Participants will contribute to the capital of the Joint Venture, in cash or property in agreed upon value. All Participants will contribute their respective Contributions as agreed.\n\nWithdrawal of Capital\n\nNo participant will withdraw any portion of their Contribution without the express written consent of the other Participant.\n\nAdditional Capital\n\nCapital Contributions may be amended from time to time, according to the requirements of the Joint Venture provided that the interests of the Participants are not affected, except with the unanimous consent of the Participants. No Participant will be required\n\n2.\n\n3.\n\n4.\n\n5.\n\n6.\n\n7.\n\n8.\n\n\n\n\n\nto make Additional Capital Contributions. Whenever additional capital is determined to be required and an individual Participant is unwilling or unable to meet the additional contribution requirement within a reasonable period, as required by Joint Venture business obligations, remaining Participants may contribute in proportion to their existing Capital Contributions to resolve the amount in default. In such case the allocation of profits or losses among all the Participants will be adjusted to reflect the aggregate change in Capital Contributions by the Participants.\n\nAny advance of money to the Joint Venture by any Participant in excess of  the amounts provided for  in  th is  Agreement or subsequently agreed to as Additional Capital Contribution will be deemed a debt owed by the Joint Venture and not an increase in Capital Contribution of the Participant. This liability will be repaid with interest at rates and times to be determined by a majority of the Participants within the limits of what is required or permitted in the Act. This liability will not entitle the lending Participant to any increased share of the Joint Venture's profits nor to a greater voting power. Such debts may have preference or priority over any other payments to Participants as may be determined by a majority of the Participants.\n\nCapital Accounts\n\nAn individual capital account (the \"Capital Accounts\") will be maintained for each Participant and their Initial Capital Contribution will be credited to this account. Any Additional Capital Contributions made by any Participant will be credited to that Participant's individual Capital Account.\n\nInterest on Capital\n\nNo borrowing charge or loan interest will be due or payable to any Participant on their agreed Capital Contribution inclusive of any agreed Additional Capital Contributions.\n\n9.\n\n10.\n\n11.\n\n\n\n\n\nFinancial Decisions\n\nDecisions regarding the distribution of profits, allocation of losses, and the requirement for Additional Capital Contributions as well as all other financial matters will be decided by a unanimous vote of the Participants.\n\nProfit and Loss\n\nSubject to any other provisions of this Agreement, the net profits and losses of the Joint Venture, for both accounting and tax purposes, will accrue to and be borne by the Participants in proportion to the Participants' Capital Contributions inclusive of any Additional Capital Contributions (the \"Profit and Loss Distribution\").\n\nBooks of Account\n\nAccurate and complete books of account of the transactions of the Joint Venture will be kept in accordance with generally accepted accounting principles (GAAP) and at all reasonable times will be available and open to inspection and examination by any Participant. The books and records of the Joint Venture will reflect all the Joint Venture's transactions and will be appropriate and adequate for the business conducted by the Joint Venture.\n\nAnnual Report\n\nAs soon as practicable after the close of each fiscal year, the Joint Venture will furnish to each Participant an annual report showing a full and complete account of the condition of the Joint Venture. This report will consist of at least the following documents:\n\na statement of all information as will be necessary for the preparation of each Participant's income or other tax returns;\n\na copy of the Joint Venture's federal income tax returns for that fiscal year;\n\n12.\n\n13.\n\n14.\n\n15.\n\na.\n\nb.\n\n\n\n\n\nsupporting income statement;\n\na balance sheet;\n\na cash flow statement;\n\na breakdown of the profit and loss attributable to each Participant; and\n\nany additional information that the Participants may require.\n\nBanking and Joint Venture Funds\n\nThe funds of the Joint Venture will be placed in such investments and banking accounts as will be designated by the Participants. Joint Venture funds will be held in the name of the Joint Venture and will not be commingled with those of any other person or entity.\n\nFiscal Year\n\nThe fiscal year will end on the 31st day of December of each year.\n\nAudit\n\nAny of the Participants will have the right to request an audit of the Joint Venture books. The cost of the audit will be borne by the Joint Venture. The audit will be performed by an accounting firm acceptable to all the Participants. Not more than one (1) audit will be required by any or all of the Participants for any fiscal year.\n\nManagement\n\nExcept as all of the Participants may otherwise agree in writing, all actions and decisions respecting the management, operation and control of the Joint Venture and its business will be decided by a majority vote of the Participants.\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\n16.\n\n17.\n\n18.\n\n19.\n\n\n\n\n\nContract Binding Authority\n\nAll actions and decisions with respect to binding the Joint Venture in contract requires the consent of a majority of the Participants.\n\nTax Matters Participant\n\nThe tax matters Participant will be MJ Syndicated Inc. (the \"Tax Matters Participant\"). The Tax Matters Participant will prepare, or cause to be prepared, all tax returns and reports for the Joint Venture and make any related elections that the Participants deem advisable.\n\nA Tax Matters Participant can voluntarily withdraw from the position of Tax Matters Participant or can be appointed or replaced by a majority vote of the other Participants. In the event of a withdrawal of the Tax Matters Participant from the Joint Venture, the remaining Participants will appoint a successor as soon as practicable.\n\nMeetings\n\nRegular meetings of the Participants will be held quarterly.\n\nAny Participant can call a special meeting to resolve issues that require a vote, as indicated by this Agreement, by providing all Participants with reasonable notice. In the case of a special vote, the meeting will be restricted to the specific purpose for which the meeting was held.\n\nAll meetings will be held at a time and in a location that is reasonable, convenient and practical considering the situation of all Participants.\n\nAdmitting a New Participant\n\nA new Participant may only be admitted to the Joint Venture with a unanimous vote of the existing Participants.\n\n20.\n\n21.\n\n22.\n\n23.\n\n24.\n\n25.\n\n26.\n\n\n\n\n\nAny new Participant agrees to be bound by all the covenants, terms, and conditions of this Agreement, inclusive of all current and future amendments. Further, a new Participant will  execute such documents as are needed to affect the admission of the new Participant. Any new Participant will receive such business interest in the Joint Venture as determined by a unanimous decision of the other Participants.\n\nVoluntary Withdrawal of a Participant\n\nAny Participant will have the right to voluntarily withdraw from the Joint Venture at any time. Written notice of intention to withdraw must be served in writing upon the remaining Participants at least Thirty (30) business days prior to the withdrawal date.\n\nThe voluntary withdrawal of a Participant will  result in the dissolution of the Joint Venture.\n\nA Dissociated Participant will only exercise the right to withdraw in good faith and will act to minimize any present or future harm done to the remaining Participants as a result of the withdrawal.\n\nInvoluntary Withdrawal of a Participant\n\nEvents resulting in the involuntary withdrawal of a Participant from the Joint Venture will include, but not be limited to: death of a Participant; Participant mental incapacity; Participant disability preventing reasonable participation in the Joint Venture; Participant incompetence; breach of fiduciary duties by a Participant; criminal conviction of a Participant; Expulsion of a Participant; Operation of Law against a Participant; or any act or omission of a Participant that can reasonably be expected to bring the business or societal reputation of the Joint Venture into disrepute.\n\nThe involuntary withdrawal of a Participant will result in the dissolution of the Joint Venture.\n\n27.\n\n28.\n\n29.\n\n30.\n\n31.\n\n32.\n\n\n\n\n\nA trustee in bankruptcy or similar third party who may acquire that Dissociated Participant's interest in the Joint Venture will only acquire that Participant's economic rights and interests and will not acquire any other rights of that Participant or be admitted as a Participant of the Joint Venture or have the right to exercise any management or voting interests.\n\nDissociation of a Participant\n\nWhere the dissociation of a Participant for any reason results in the dissolution of the Joint Venture then the Joint Venture will proceed in a reasonable and timely manner to dissolve the Joint Venture, with all debts being paid first, prior to any distribution of the remaining funds. Valuation and distribution will be determined as described in the Valuation of Interest section of this Agreement.\n\nThe remaining Participants retain the right to seek damages from a Dissociated Participant where the dissociation resulted from a malicious or criminal act by the Dissociated Participant or where the Dissociated Participant had breached their fiduciary duty to the Joint Venture or was in breach of this Agreement or had acted in a way that could reasonably be foreseen to bring harm or damage to the Joint Venture or to the reputation of the Joint Venture.\n\nDissolution\n\nExcept as otherwise provided in this Agreement, the Joint Venture may be dissolved only with the unanimous consent of all Participants.\n\nDistribution of Property on Dissolution of Joint Venture\n\nIn the event of the dissolution of the Joint Venture, each Participant will share in any remaining assets or liabilities of the Joint Venture in proportion to the Participants' Capital Contributions inclusive of any Additional Capital Contributions (the \"Dissolution Distribution\").\n\n33.\n\n34.\n\n35.\n\n36.\n\n37.\n\n\n\n\n\nUpon Dissolution of the Joint Venture and liquidation of Joint Venture Property, and after payment of all selling costs and expenses, the liquidator will distribute the Joint Venture assets to the following groups according to the following order of priority:\n\nin satisfaction of liabilities to creditors except Joint Venture obligations to current Participants;\n\nin satisfaction of Joint Venture debt obligations to current Participants; and then\n\nto the Participants according to the Dissolution Distribution described above.\n\nThe claims of each priority group will be satisfied in full before satisfying any claims of a lower priority group. Any excess of Joint Venture assets after liabilities or any insufficiency in Joint Venture assets in resolving liabilities under this section will be shared by the Participants according to the Dissolution Distribution described above.\n\nValuation of Interest\n\nIn the absence of a written agreement setting a value, the value of the Joint Venture will be based on the fair market value appraisal of all Joint Venture assets (less liabilities) determined in accordance with generally accepted accounting principles (GAAP). This appraisal will be conducted by an independent accounting firm agreed to by all Participants. An appraiser will be appointed within a reasonable period of the date of withdrawal or dissolution. The results of the appraisal will be binding on all Participants. A withdrawing Part ic ipant 's  interest  wi l l  be based on that Participant's proportion of the Dissolution Distribution described above, less any outstanding liabilities the withdrawing Participant may have to the Joint Venture. The intent of this section is to ensure the survival of the Joint Venture despite the withdrawal of any individual Participant.\n\n38.\n\na.\n\nb.\n\nc.\n\n39.\n\n40.\n\n\n\n\n\nNo allowance will be made for goodwill, trade name, patents or other intangible assets, except where those assets have been reflected on the Joint Venture books immediately prior to valuation.\n\nGoodwill\n\nThe goodwill of the Joint Venture business will be assessed at an amount to be determined by appraisal using generally accepted accounting principles (GAAP).\n\nTitle to Joint Venture Property\n\nTitle to all Joint Venture Property will remain in the name of the Joint Venture. No Participant or group of Participants will have any ownership interest in such Joint Venture Property in whole or in part.\n\nVoting\n\nAny vote required by the Joint Venture will be assessed where each Participant receives one vote carrying equal weight.\n\nForce Majeure\n\nA Participant will be free of liability to the Joint Venture where the Participant is prevented from executing their obligations under this Agreement in whole or in part due to force majeure, such as earthquake, typhoon, flood, fire, and war or any other unforeseen and uncontrollable event where the Participant has communicated the circumstance of said event to any and all other Participants and taken any and all appropriate action to mitigate said event.\n\nDuty of Loyalty\n\nNo Participant will engage in any business, venture or transaction, whether directly or indirectly, that might be competitive with the business of the Joint Venture or that would be in direct conflict of\n\n41.\n\n42.\n\n43.\n\n44.\n\n45.\n\n46.\n\n\n\n\n\ninterest to the Joint Venture without the unanimous written consent of the remaining Participants. Any and all businesses, ventures or transactions with any appearance of conflict of interest must be fully disclosed to all other Participants. Failure to comply with any of the terms of this clause will be deemed an Involuntary Withdrawal of the offending Participant and may be treated accordingly by the remaining Participants.\n\nDuty of Accountability for Private Profits\n\nEach Participant must account to the Joint Venture for any benefit derived by that Participant without the consent of the other Participants from any transaction concerning the Joint Venture or any use by that Participant of the Joint Venture property, name or business connection.  This duty continues to apply to any transactions undertaken after the Joint Venture has been dissolved but before the affairs of the Joint Venture have been completely wound up by the surviving Participant or Participants or their agent or agents.\n\nDuty to Devote Time\n\nEach Participant will devote such time and attention to the business of the Joint Venture as the majority of the Participants will from time to time reasonably determine for the conduct of the Joint Venture business.\n\nActions Requiring Unanimous Consent of the Participants\n\nThe following list of actions will require the unanimous consent of all Participants:\n\ncommitting the Joint Venture to new liabilities or obligations totaling To Be Determined;\n\nand\n\nincurring single expenditures that exceed \"To Be Determined\".\n\n47.\n\n48.\n\n49.\n\na.\n\nb.\n\n\n\n\n\nAny losses incurred as a result of a violation of this section will be charged to and collected from the individual Participant that acted without unanimous consent and caused the loss.\n\nForbidden Acts\n\nNo Participant may do any act in contravention of this Agreement.\n\nNo Participant may permit, intentionally or unintentionally, the assignment of express, implied or apparent authority to a third party that is not a Participant in the Joint Venture.\n\nNo Participant may do any act that would make it impossible to carry on the ordinary business of the Joint Venture.\n\nNo Participant may confess a judgment against the Joint Venture.\n\nNo Participant will have the right or authority to bind or obligate the Joint Venture to any extent with regard to any matter outside the intended purpose of the Joint Venture.\n\nAny violation of the above Forbidden Acts will be deemed an Involuntary Withdrawal of the offending Participant and may be treated accordingly by the remaining Participants.\n\nIndemnification\n\nAll Participants will be indemnified and held harmless by the Joint Venture from and against any and all claims of any nature, whatsoever, arising out of a Participant's participation in Joint Venture affairs. A Participant will not be entitled to indemnification under this section for liability arising out of gross negligence or wil l ful  misconduct of the Participant or the breach by the Participant of any provisions of this Agreement.\n\nLiability\n\n50.\n\n51.\n\n52.\n\n53.\n\n54.\n\n55.\n\n56.\n\n57.\n\n\n\n\n\nA Participant will not be liable to the Joint Venture, or to any other Participant, for any mistake or error in judgment or for any act or omission done in good faith and believed to be within the scope of authority conferred or implied by this Agreement or the Joint Venture.\n\nLiability Insurance\n\nThe Joint Venture may acquire insurance on behalf of any Participant, employee, agent or other person engaged in the business interest of the Joint Venture against any liability asserted against them or incurred by them while acting in good faith on behalf of the Joint Venture.\n\nAmendments\n\nThis Agreement may not be amended in whole or in part without the unanimous written consent of all Participants.\n\nJurisdiction\n\nThe Participants submit to the jurisdiction of the courts of The State of Florida for the enforcement of this Agreement or any arbitration award or decision arising from this Agreement.\n\nDefinitions\n\nFor the purpose of this Agreement, the following terms are defined as follows:\n\n\"Additional Capital Contributions\" means Capital Contributions, other than Initial Capital Contributions, made by Participants to the Joint Venture.\n\n\"Capital Contribution\" means the total amount of cash or Property contributed to the Joint Venture by any one Participant.\n\n58.\n\n59.\n\n60.\n\n61.\n\na.\n\nb.\n\n\n\n\n\n\"Dissociated Participant\" means any Participant who is removed from the Joint Venture through a voluntary or involuntary withdrawal as provided in this Agreement.\n\n\"Expulsion of a Participant\" can occur on application by the Joint Venture or another Participant, where it has been determined that the Participant:\n\nhas engaged in wrongful conduct that adversely and materially affected the Joint Venture's business;\n\nhas willfully or persistently committed a material breach of this Agreement or of a duty owed to the Joint Venture or to the other Participants; or\n\nhas engaged in conduct relating to the Joint Venture's business that makes it not reasonably practicable to carry on the business with the Participant.\n\n\"Initial Capital Contribution\" means Capital Contributions made by any Participant to acquire an interest in the Joint Venture.\n\n\"Operation of Law\" means rights or duties that are cast upon a party by the law, without any act or agreement on the part of the individual including, but not limited to, an assignment for the benefit of creditors, a divorce, or a bankruptcy.\n\nMiscellaneous\n\nTime is of the essence in this Agreement.\n\nThis Agreement may be executed in counterpart.\n\nHeadings are inserted for the convenience of the parties only and are not to be considered when interpreting this Agreement. Words in the singular mean and include the plural and vice versa. Words in the\n\nc.\n\nd.\n\ni.\n\nii.\n\niii.\n\ne.\n\nf.\n\n62.\n\n63.\n\n64.\n\n\n\n\n\nmasculine gender include the feminine gender and vice versa. Words in the neuter gender include the masculine gender and the feminine gender and vice versa.\n\nIf any term, covenant, condition or provision of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, it is the parties' intent that such provision be reduced in scope by the court only to the extent deemed necessary by that court to render the provision reasonable and enforceable and the remainder of the provisions of this Agreement will in no way be affected, impaired or invalidated as a result.\n\nThis Agreement contains the entire agreement between the parties. All negotiations and understandings have been included in this Agreement. Statements or representations which may have been made by any party to this Agreement in the negotiation stages of this Agreement may in some way be inconsistent with this final written Agreement. All such statements are declared to be of no value in this Agreement. Only the written terms of this Agreement will bind the parties.\n\nThis Agreement and the terms and conditions contained in this Agreement apply to and are binding upon the Participant's successors, assigns, executors, administrators, beneficiaries, and representatives.\n\nAny notices or delivery required here will be deemed completed when hand-delivered, delivered by agent, or seven (7) days after being placed in the post, postage prepaid, to the parties at the addresses contained in this Agreement or as the parties may later designate in writing.\n\nAll of the rights, remedies and benefits provided by this Agreement will be cumulative and will not be exclusive of any other such rights, remedies and benefits allowed by law.\n\nIN WITNESS WHEREOF the Participants have duly affixed their signatures under hand on this 27th day of November 2018.\n\n65.\n\n66.\n\n67.\n\n68.\n\n69.\n\n\n\n\n\nSimply Herbals\n\nPer: ____________________\n\nCEO: MJ Syndicated, Inc CEO: Simply Herbals, Inc.\n\nMJ Syndicated, Inc.\n\nPer: __/s/ Maxine Pierson________"
  }
]